Kit for detecting acute myeloid leukemia susceptibility
A technology for acute myeloid leukemia, applied in the field of kits for detecting the susceptibility of acute myeloid leukemia, can solve the problem of not predicting acute myeloid leukemia, and achieve the effect of wide application
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0020] A kit for detecting susceptibility to acute myeloid leukemia, comprising: a pair of specific primers and a pair of specific fluorescent probes for detecting the SNP site rs11821102 on the CD44 gene, Taq DNA polymerase, dNTP mixture, MgCl2 solution, Fluorescent quantitative PCR reaction buffer and deionized water;
[0021] The sequence of the specific primer pair for detecting the rs11821102 SNP site on the CD44 gene is shown in the sequence table SEQ ID NO: 1 and SEQ ID NO: 2, the Tm value of the sense primer sequence is 60 °C, and the antisense primer sequence The Tm value is 58°C; the sequence of the specific fluorescent probe pair for detecting the rs11821102 SNP site on the CD44 gene is shown in the sequence table SEQ ID NO: 3 and SEQ ID NO: 4, and the Tm of the wild-type probe sequence The value is 66°C, and the Tm value of the mutant probe sequence is 67°C;
[0022] The specific primer can specifically amplify a pair of DNA primers and a pair of DNA probes agains...
Embodiment 2
[0028] Step 1: Extraction of DNA
[0029] The subjects were consulted before the service, and the subjects signed the informed consent and filled out the questionnaire on living and eating habits. 5ml of EDTA anticoagulated blood was extracted by conventional method. Genomic DNA of blood samples was extracted by silica gel adsorption method.
[0030] Step 2: Genotyping Assays
[0031] Using the kit described in Example 1, perform fluorescence quantitative PCR detection on the SNP site rs11821102 on the CD44 gene of the DNA of the subject to be tested, and determine the genotype of the site.
[0032] Step 3: Instruct people to proactively prevent acute myeloid leukemia
[0033] Through the analysis of the genotype of the tested person, the genotyping test report and the individualized health guidance report for the tested person are issued. The genotyping test report details the susceptibility and probability of acute myeloid leukemia of the tested person. The individualiz...
Embodiment 3
[0035] After genotyping 314 patients with acute myeloid leukemia and 615 normal controls by the method we designed, the obtained data are drawn in Table 1:
[0036] Table 1. CD44 gene rs11821102 single nucleotide polymorphism and risk of breast cancer
[0037]
[0038] It can be seen from Table 1 that individuals carrying the CD44 rs11821102 AA genotype have a 3.05-fold higher risk of developing acute myeloid leukemia than individuals carrying the CD44 rs11821102 GG genotype, and individuals carrying the CD44 rs11821102 AG genotype The risk of developing acute myeloid leukemia was 1.68 times higher (the differences were all significant in the trend test, P < 0.05).
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com